Revenue rose 12.1% year over year in Q2 and beat analyst estimates by $10.5 million in Q2 2025. EPS were $0.30 for Q2 2025, slightly missing expectations. Adjusted EPS increased 11.1% year over year.

AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney ...

Stock index futures rose on Tuesday, as investors turned their focus to a big week for earnings and labor reports. S&P 500 ...

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...

JPMorgan U.S. Tech Leaders ETF's active strategy targets 63 tech leaders across sectors. See here to know why we rate JTEK ...

Texas Yale Capital Corp. just purchased a fresh batch of Intuit Inc. shares, signaling a sweet spot for potential investors.

Firetrail Investments PTY Ltd. has juiced up its portfolio by snapping up 11,650 shares of ServiceNow, tagging a cool $9.4 ...